BACTERIOCINS OF ENTEROTOXIGENIC STAPHYLOCOCCI: CURRENT VIEW OF THEIR ECOLOGICAL AND PATHOGENETIC SIGNIFICANCE IN PEDIATRICS
DOI:
https://doi.org/10.30888/2663-5712.2025-34-05-085Keywords:
bacteriocins, Staphylococcus aureus, enterotoxins, virulence factors, ecological role, genetic regulationAbstract
The aim of the review is to summarize current knowledge on bacteriocins of enterotoxigenic staphylococci, their ecological role in the human microbiota, and their pathogenetic significance in the development of infections in children. The review analyzesReferences
Newstead L, Varjonen K, Nuttall T, Paterson G. Staphylococcal-produced bacteriocins and antimicrobial peptides: their potential as alternative treatments for Staphylococcus aureus infections. Antibiotics. 2020;9(2):40. doi:10.3390/
antibiotics9020040.
Sato T, et al. C55 bacteriocin produced by ETB-plasmid positive Staphylococcus aureus strains is a key factor for competition with S. aureus strains. Microbiol Immunol. 2016;60(5):299-305. doi:10.1111/1348-0421.12345.
O’Connor PM, et al. Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity. BMC Microbiol. 2007;7:24. doi:10.1186/1471-2180-7-24.
Jaumaux F, Petit K, Martin A, et al. Selective bacteriocins: a promising treatment for Staphylococcus aureus skin infections. Antibiotics. 2023;12(6):947. doi:10.3390/antibiotics12060947.
Grundmann H, et al. Enterotoxin gene content in Staphylococcus aureus from the human intestinal tract. FEMS Microbiol Lett. 2009;296(1):72-78. doi:10.1111/j.1574-6968.2009.01521.x.
Haryfulina MA, Voronkova OS, Shevchenko TM, Vinnikov AI. Characterization of staphylococci and their role in pathology of children. Regul Mech Biosyst. 2023;14(2):158-165. doi:10.15421/021422.
Safaei HR, Dormanesh B, Pirasteh H, Pournasiri Z. Study the enterotoxigenicity of Staphylococcus aureus isolated from the urine samples of pediatrics with UTIs. Biomed Pharmacol J. 2015;8(Spec Issue):379-385.
Hanchi H, Kouidhi B, Al Atya H, Christofi N, Bakhrouf A. Evaluating the translational potential of bacteriocins as an alternative treatment for S. aureus infections in animals and humans. Int J Antimicrob Agents. 2023;62(3):106756.
Sukiasyan A, Madoyan R, Alchujyan N, et al. Bacteriocin-producing probiotic lactic acid bacteria against hospital strains of S. aureus and E. coli. Med Clin Res. 2023;8(12):01-07.
Mittu B, Neha. Bacteriocin production from Staphylococcus aureus: review. Bioequiv Bioavailab Int J. 2024;8(2). doi:10.23880/beba-16000237.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
